NASDAQ:MLEC Moolec Science (MLEC) Stock Price, News & Analysis $1.01 -0.02 (-1.94%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$1.00▼$1.0450-Day Range$0.89▼$1.3252-Week Range$0.83▼$3.40Volume11,850 shsAverage Volume820,063 shsMarket Capitalization$37.94 millionP/E RatioN/ADividend YieldN/APrice Target$5.50 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestTrends Get Moolec Science alerts: Email Address Moolec Science MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside444.5% Upside$5.50 Price TargetShort InterestHealthy1.54% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.63Based on 3 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.62 out of 5 starsConsumer Staples Sector93rd out of 136 stocksHolding & Other Investment Offices Industry4th out of 16 stocks 3.5 Analyst's Opinion Consensus RatingMoolec Science has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageMoolec Science has received no research coverage in the past 90 days.Read more about Moolec Science's stock forecast and price target. Previous Next 5.0 Short Interest Percentage of Shares Shorted1.54% of the float of Moolec Science has been sold short.Short Interest Ratio / Days to CoverMoolec Science has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Moolec Science has recently decreased by 12.31%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldMoolec Science does not currently pay a dividend.Dividend GrowthMoolec Science does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for MLEC. Previous Next 3.1 News and Social Media Coverage News SentimentMoolec Science has a news sentiment score of 0.63. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.50 average news sentiment score of Consumer Staples companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Moolec Science this week, compared to 0 articles on an average week.MarketBeat Follows1 people have added Moolec Science to their MarketBeat watchlist in the last 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Moolec Science insiders have not sold or bought any company stock.Percentage Held by Insiders19.90% of the stock of Moolec Science is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 0.07% of the stock of Moolec Science is held by institutions.Read more about Moolec Science's insider trading history. Previous Next 0.0 Earnings and Valuation Price to Book Value per Share RatioMoolec Science has a P/B Ratio of 3.74. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Moolec Science's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad American Hartford Gold GroupDave Ramsey Makes Big Mistake Live On AirDave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.GET THE FREE GUIDE About Moolec Science Stock (NASDAQ:MLEC)Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.Read More MLEC Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MLEC Stock News HeadlinesJuly 25 at 2:52 AM | americanbankingnews.comMoolec Science (NASDAQ:MLEC) Trading Down 3.7%July 25 at 2:00 AM | americanbankingnews.comHead to Head Survey: Moolec Science (NASDAQ:MLEC) and Black Mountain Acquisition (NYSE:BMAC)July 26, 2024 | DTI (Ad)How a $0.25 cent option contract makes my top traders feelIf you don’t know me, I’ve been in the markets for over 40 years… but recently, I’ve discovered a breakthrough that might be my favorite strategy of ALL time! While I kept the finer details of these $0.25 Cent Trades under wraps until recently…July 16, 2024 | benzinga.comTop 4 Risk Off Stocks You'll Regret Missing In JulyJuly 15, 2024 | investorplace.comWhy Is Moolec Science (MLEC) Stock Down 18% Today?May 31, 2024 | gurufocus.comQ3 2024 Moolec Science SA Earnings Call TranscriptMay 30, 2024 | investorplace.comMLEC Stock Earnings: Moolec Science Beats EPS for Q3 2024May 23, 2024 | finance.yahoo.comMoolec Science to Host Third Quarter Fiscal Year 2024 Business Update Conference CallJuly 26, 2024 | DTI (Ad)How a $0.25 cent option contract makes my top traders feelIf you don’t know me, I’ve been in the markets for over 40 years… but recently, I’ve discovered a breakthrough that might be my favorite strategy of ALL time! While I kept the finer details of these $0.25 Cent Trades under wraps until recently…May 9, 2024 | finanznachrichten.deMediprogen Inc.: Mediprogen Has Entered Into Commercial Discussions With Moolec to Expand Their Technology Into the Cosmetics Global MarketApril 24, 2024 | msn.comImmutep, Capricor Therapeutics, Cyclacel Pharmaceuticals among healthcare moversApril 24, 2024 | seekingalpha.comMLEC Moolec Science SAApril 23, 2024 | msn.comTop 2 Risk Off Stocks You May Want To Dump In Q2April 22, 2024 | marketwatch.comMoolec Science Shares Rise 69% After USDA Approval for Plant-Grown Animal ProteinApril 22, 2024 | msn.comWhy Shares Of Moolec Science Are Skyrocketing TodayApril 22, 2024 | investorplace.comWhy Is Moolec Science (MLEC) Stock Up 121% Today?April 22, 2024 | investorplace.comWhy Is Moolec Science (MLEC) Stock Up 121% Today?March 16, 2024 | markets.businessinsider.comVendetti Reaffirms Buy Rating for Moolec Science Highlighting Strong Financials and R&D ProgressSee More Headlines Receive MLEC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Moolec Science and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/30/2024Today7/26/2024Next Earnings (Estimated)11/04/2024Fiscal Year End6/30/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorConsumer Staples Industry Holding & other investment offices Sub-IndustryTrading Current SymbolNASDAQ:MLEC CUSIPN/A CIK1937737 Webmoolecscience.com Phone650-515-3930FaxN/AEmployees4Year FoundedN/APrice Target and Rating Average Stock Price Target$5.50 High Stock Price Target$6.00 Low Stock Price Target$5.00 Potential Upside/Downside+444.5%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-51,790,000.00 Net Margins-150.27% Pretax Margin-247.39% Return on Equity-87.89% Return on Assets-33.26% Debt Debt-to-Equity Ratio0.89 Current Ratio0.43 Quick Ratio0.37 Sales & Book Value Annual Sales$900,000.00 Price / Sales42.15 Cash FlowN/A Price / Cash FlowN/A Book Value$0.27 per share Price / Book3.74Miscellaneous Outstanding Shares37,560,000Free Float30,089,000Market Cap$37.94 million OptionableNot Optionable Beta-0.54 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesMr. Gaston Paladini M.B.A. (Age 43)Co-Founder, CEO & Director Mr. Henk Hoogenkamp Ph.D. (Age 37)Co-Founder & Chief Product Officer Mr. Martin Salinas Ph.D. (Age 42)Chief of Technology & Co-Founder Mr. Jose Lopez Lecube M.B.A. (Age 41)CFO & Director Mr. Amit Dhingra Ph.D. (Age 54)Chief Science Officer Ms. Catalina Jones B.A. (Age 38)Chief of Staff & Sustainability More ExecutivesKey CompetitorsGranite Point Mortgage TrustNYSE:GPMTGreat AjaxNYSE:AJXRF Acquisition Corp IINASDAQ:RFAIEllington CreditNYSE:EARNBlockchain Coinvestors Acquisition Corp. INASDAQ:BCSAView All Competitors MLEC Stock Analysis - Frequently Asked Questions How have MLEC shares performed this year? Moolec Science's stock was trading at $2.46 at the beginning of 2024. Since then, MLEC shares have decreased by 58.9% and is now trading at $1.0101. View the best growth stocks for 2024 here. How were Moolec Science's earnings last quarter? Moolec Science SA (NASDAQ:MLEC) announced its earnings results on Thursday, May, 30th. The company reported ($0.04) EPS for the quarter. The company had revenue of $2.11 million for the quarter. Moolec Science had a negative trailing twelve-month return on equity of 87.89% and a negative net margin of 150.27%. How do I buy shares of Moolec Science? Shares of MLEC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:MLEC) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” ...Porter & Company | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Moolec Science SA Please log in to your account or sign up in order to add this asset to your watchlist. Share Moolec Science With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
